💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Adamas Pharmaceuticals, Inc. (ADMS)
« Back to company indexADMS Chatter Timeline
Stock Ticker for ADMS
Most Active Tweeters for ADMS
| User | Tweets |
|---|---|
| @stocknewstimes | 4 |
| @FlashAlert_me | 3 |
| @HealthcareBeat | 3 |
| @AmericanBanking | 3 |
| @WatchlistN | 2 |
Recent Tweets for ADMS
 |
@SwingTradeBot 20 DMA Support today: $REM $ADMS ... https://t.co/deOpbNqdR6 July 15th 2020, 3:07pm |
 |
@StockNewsNow $ADMS Adamas presents new post-hoc Phase 3 data analysis for GOCOVRI® in Parkinson’s disease at the 2020 American A… https://t.co/9zbxrKqD9C July 15th 2020, 3:07pm |
 |
@HealthcareBeat Adamas announces post-hoc data supporting benefit of Gocovri in Parkinson's $ADMS https://t.co/FArs8VZqRK July 15th 2020, 11:07am |
 |
@MarketCurrents $ADMS - Adamas announces post-hoc data supporting benefit of Gocovri in Parkinson's https://t.co/3fVChnHgFm July 15th 2020, 11:07am |
 |
@sbwcws Adamas presents post-hoc Phase 3 data analysis for GOCOVRI $ADMS July 15th 2020, 8:07am |
 |
@otcdynamics $ADMS Adamas presents new post-hoc Phase 3 data analysis for GOCOVRI® in Parkinson’s disease at the 2020 American A… https://t.co/1Lj8VCqFq8 July 15th 2020, 8:07am |
 |
@FlashAlert_me $ADMS [15s. delayed]: Issued Press Release on July 15, 08:00:00: Adamas presents new post-hoc Phase 3 data analysis… https://t.co/jef4G3ic5j July 15th 2020, 8:07am |
 |
@stocknewstimes -$0.60 Earnings Per Share Expected for Adamas Pharmaceuticals Inc $ADMS This Quarter https://t.co/MaRn5pLDpW July 14th 2020, 2:07pm |
|
@stocknewstimes Zacks: Analysts Anticipate Adamas Pharmaceuticals Inc $ADMS Will Post Quarterly Sales of $15.63 Million https://t.co/o15C7Xftx3 July 14th 2020, 1:07pm |
 |
@fm23 $ADMS https://t.co/w3pfAOS8yZ July 13th 2020, 4:07pm |
 |
@bbnsnews Analysts Set Adamas Pharmaceuticals Inc $ADMS PT at $9.67 https://t.co/4kK4ksRihG July 13th 2020, 11:07am |
 |
@ConsumerFeed Adamas Pharmaceuticals Inc $ADMS Expected to Post Earnings of -$0.60 Per Share https://t.co/qTmz0tD5U8 July 12th 2020, 6:07am |
 |
@WatchlistN Adamas Pharmaceuticals Inc $ADMS Expected to Post Earnings of -$0.60 Per Share https://t.co/BF26aBQFP8 July 12th 2020, 6:07am |
 |
@ThisLincolnian Adamas Pharmaceuticals $ADMS Trading 6.3% Higher https://t.co/ueh5jGFzvL July 12th 2020, 2:07am |
|
@ConsumerFeed Analysts Set Adamas Pharmaceuticals Inc $ADMS PT at $9.67 https://t.co/QwWwulSnmq July 11th 2020, 6:07am |
|
@WatchlistN Adamas Pharmaceuticals Inc $ADMS Receives $9.67 Consensus Target Price from Brokerages https://t.co/PjY3u12pMf July 11th 2020, 6:07am |
|
@HealthcareBeat Form SC 13G/A (statement of acquisition of beneficial ownership by individuals) filed with the SEC $ADMS https://t.co/Za3K2BOIEJ July 11th 2020, 6:07am |
 |
@EnterpriseLeade Zacks: Analysts Anticipate Adamas Pharmaceuticals Inc $ADMS Will Post Quarterly Sales of $15.63 Million https://t.co/AyyDudANEg July 11th 2020, 3:07am |
 |
@AmericanBanking Zacks: Analysts Expect Adamas Pharmaceuticals Inc $ADMS Will Announce Quarterly Sales of $15.63 Million https://t.co/3HFCtivk9f #stocks July 11th 2020, 3:07am |
|
@otcdynamics $ADMS Adamas Announces New Employment Inducement Grant https://t.co/hJ4ZudX5wp July 10th 2020, 4:07pm |
|
@FlashAlert_me $ADMS [15s. delayed]: Issued Press Release on July 10, 16:05:00: Adamas Announces New Employment Inducement Grant https://t.co/76kzQZ1zzV July 10th 2020, 4:07pm |
|
@HealthcareBeat Adamas Announces New Employment Inducement Grant $ADMS https://t.co/PXQzFecsi1 July 10th 2020, 4:07pm |
 |
@stock_titan $ADMS Adamas Announces New Employment Inducement Grant https://t.co/idcEe8J8oV July 10th 2020, 4:07pm |
 |
@EdgarInsider FORM SC 13G/A recently SEC filed. $ADMS $BLK Adamas Pharmaceuticals Inc BlackRock Inc https://t.co/0WNxQe5RFd July 10th 2020, 10:07am |
 |
@fintel_io BlackRock Inc. has filed an amended 13G/A, reporting 2.1% ownership in $ADMS - https://t.co/EXp6PHrtCr July 10th 2020, 10:07am |
|
@FlashAlert_me $ADMS [15s. delayed] filed form SC 13G/A on July 10, 10:39:33 https://t.co/Egc2ApOE5v July 10th 2020, 10:07am |
|
@AmericanBanking Adamas Pharmaceuticals Inc $ADMS Expected to Post Earnings of -$0.60 Per Share https://t.co/W25ksVYZpF #stocks July 9th 2020, 11:07am |
 |
@OlympiaReport Adamas Pharmaceuticals Inc $ADMS Expected to Post Earnings of -$0.60 Per Share https://t.co/uLbldcUbls July 9th 2020, 11:07am |
 |
@dispatchtribune Adamas Pharmaceuticals Inc $ADMS Receives Average Recommendation of “Hold” from Analysts https://t.co/t6llfXKKWC July 8th 2020, 11:07am |
|
@AmericanBanking Adamas Pharmaceuticals Inc $ADMS Receives Average Recommendation of “Hold” from Analysts https://t.co/Sjdd2y3KYk #stocks July 8th 2020, 11:07am |
|
@stocknewstimes Adamas Pharmaceuticals Inc $ADMS Receives Average Rating of “Hold” from Analysts https://t.co/CqAtMsvzU9 July 8th 2020, 11:07am |
 |
@TranscriptDaily Adamas Pharmaceuticals Inc $ADMS Receives Average Recommendation of “Hold” from Analysts https://t.co/2Cyaph5HSn July 8th 2020, 11:07am |
|
@dispatchtribune Adamas Pharmaceuticals Inc $ADMS Short Interest Update https://t.co/E1ryBeT0xo July 8th 2020, 3:07am |
|
@stocknewstimes Adamas Pharmaceuticals Inc $ADMS Short Interest Update https://t.co/YxPGVBxLIw July 8th 2020, 3:07am |
|
@stocknewstimes Adamas Pharmaceuticals $ADMS Share Price Crosses Below Fifty Day Moving Average of $2.79 https://t.co/VtL4UFy13v July 1st 2020, 3:07pm |
 |
@DataTrials $ADMS Phase 3 A Safety and Efficacy Study of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment…NC… https://t.co/M2LmS0tEJk July 1st 2020, 6:07am |
 |
@TEIStocks $ADMS looking interesting, near a well known support line. MACD and RSI not yet ready to take action, worth a watch… https://t.co/7fGgTOKJkN June 30th 2020, 9:06am |
|
@AmericanBanking Adamas Pharmaceuticals $ADMS – Research Analysts’ Recent Ratings Changes https://t.co/B3614hBZt9 #stocks June 26th 2020, 4:06pm |
 |
@TheMarketsDaily Adamas Pharmaceuticals $ADMS Rating Lowered to Hold at Zacks Investment Research https://t.co/WBje8nMfFP June 23rd 2020, 3:06am |
|
@stocknewstimes Adamas Pharmaceuticals $ADMS Rating Lowered to Hold at Zacks Investment Research https://t.co/JpmJZCndCn June 23rd 2020, 3:06am |
|
@dispatchtribune Adamas Pharmaceuticals $ADMS Rating Lowered to Hold at Zacks Investment Research https://t.co/XZWlb86dQX June 23rd 2020, 3:06am |
|
@stocknewstimes Adamas Pharmaceuticals Inc $ADMS Sees Large Decline in Short Interest https://t.co/m6deKB9qvl June 22nd 2020, 6:06am |
|
@dispatchtribune Adamas Pharmaceuticals Inc $ADMS Sees Large Decline in Short Interest https://t.co/n5eeLZBXVF June 22nd 2020, 6:06am |
 |
@dakotafinancial Adamas Pharmaceuticals $ADMS Downgraded by Zacks Investment Research https://t.co/98yhjP4ysj June 22nd 2020, 6:06am |
|
@dakotafinancial Adamas Pharmaceuticals Inc $ADMS Sees Large Decline in Short Interest https://t.co/A9rtrBzgtl June 22nd 2020, 6:06am |
|
@TranscriptDaily Adamas Pharmaceuticals Inc $ADMS Sees Large Decline in Short Interest https://t.co/UXVe5voMwh June 22nd 2020, 6:06am |
|
@TranscriptDaily Adamas Pharmaceuticals $ADMS Downgraded by Zacks Investment Research https://t.co/2FHqvjDAWx June 22nd 2020, 6:06am |
|
@dispatchtribune Adamas Pharmaceuticals $ADMS Upgraded at Zacks Investment Research https://t.co/zagu7xQtxh June 22nd 2020, 5:06am |
|
@dakotafinancial Adamas Pharmaceuticals $ADMS Upgraded at Zacks Investment Research https://t.co/z1JXQSGQcb June 22nd 2020, 5:06am |
|
@HealthcareBeat Adamas Pharmaceuticals Upgraded at Zacks Investment Research $ADMS https://t.co/Qegp8p6nmY June 22nd 2020, 5:06am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2020. All rights reserved.
Make Better Decisions
Finding and Evaluating Generic and Branded Drug Market Entry Opportunities